Calyxo Presents Largest Clinical Evidence at AUA2026
Calyxo, Inc. will showcase its CVAC System at the AUA Annual Meeting, presenting 10 clinical abstracts that emphasize safety, efficacy, and procedural efficiency. This marks the company’s largest clinical evidence presence to date, reflecting strong momentum and increased adoption in practice.
PLEASANTON, Calif.–(BUSINESS WIRE)–Calyxo, Inc., a medical device company redefining kidney stone treatment, will arrive at the American Urological Association (AUA) Annual Meeting with strong clinical momentum, supported by an expanded evidence base and increasing adoption of the CVAC System in practice. At this year’s meeting, 10 abstracts, the highest number presented to date, will highlight safety, efficacy, and procedural efficiency, alongside multiple opportunities for hands-on, physici